Skip to the content
BIOPHAR LOGO
  • Home
  • About Us
    • Management
    • Healthcare Partners
    • Magazine
  • Our Products
    • Speciality Wise
      • AYURVEDIC Range
      • Cardiac Range
      • Critical Care Range
      • Dental Range
      • Diabetic Range
      • Derma Range
      • ENT Range
      • Gynae Range
      • GASTRO PRODUCT RANGE
      • General Physician Range
      • Neuro & Psychia
      • Ortho & Surgery Range
      • Ophthalmic Range
      • Pediatric Range
      • Urology Range
    • Promotions
      • Ortho & Surgery Range
      • Cardiac Range
      • Gastro Range
      • ENT Range
      • Gynae Range
      • Diabetic Range
      • Neuro & Psychia
      • Derma Range
      • General Physician Range
      • Ayurvedic
      • Dental Range
      • Critical Care Range
      • Ophthalmic Range
      • Pediatric Range
      • Urology Range
  • New Products
  • Home
  • About Us
    • Management
    • Healthcare Partners
    • Magazine
  • Our Products
    • Speciality Wise
      • AYURVEDIC Range
      • Cardiac Range
      • Critical Care Range
      • Dental Range
      • Diabetic Range
      • Derma Range
      • ENT Range
      • Gynae Range
      • GASTRO PRODUCT RANGE
      • General Physician Range
      • Neuro & Psychia
      • Ortho & Surgery Range
      • Ophthalmic Range
      • Pediatric Range
      • Urology Range
    • Promotions
      • Ortho & Surgery Range
      • Cardiac Range
      • Gastro Range
      • ENT Range
      • Gynae Range
      • Diabetic Range
      • Neuro & Psychia
      • Derma Range
      • General Physician Range
      • Ayurvedic
      • Dental Range
      • Critical Care Range
      • Ophthalmic Range
      • Pediatric Range
      • Urology Range
  • New Products
Contact us
Home / Upcoming Products / Begmera 25/5 – Mirabegron Extended Release 25 mg & Solifenacin Succinate 5 mg Tablets
Outway O2 - Prucalopride Tablets 2mg
Prev
Dixer 50 Gel - Diclofenac Diethylamine Methyl Salicylate Oleum Lini and Menthol Gel
Next
Begmera 25/5  -  Mirabegron Extended Release 25 mg & Solifenacin Succinate 5 mg Tablets

Begmera 25/5 – Mirabegron Extended Release 25 mg & Solifenacin Succinate 5 mg Tablets

Begmera 25/5 – Mirabegron Extended Release 25 mg & Solifenacin Succinate 5 mg Tablets

Brand: Biophar®
Brand Name: Begmera 25/5
Composition: Mirabegron Extended Release 25 mg & Solifenacin Succinate 5 mg Tablets
Dosage Form: Tablets
Packing: 10*10
Category: Tablets

Categories: New Products, Uncategorized, Upcoming Products Tags: Begmera 25/5 - Mirabegron Extended Release 25 mg & Solifenacin Succinate 5 mg Tablets, Mirabegron Extended Release 25 mg & Solifenacin Succinate 5 mg Tablets, PCD Franchise Mirabegron Extended Release 25 mg & Solifenacin Succinate 5 mg Tablets, Pharma Franchise Mirabegron Extended Release 25 mg & Solifenacin Succinate 5 mg Tablets, Third Party Manfacturing Mirabegron Extended Release 25 mg & Solifenacin Succinate 5 mg Tablets

Related products

  • Adaplist Gel

    Clindamycin Phosphate and Adapalene Gel

    New Products,Uncategorized,Upcoming Products
  • Celeref 200

    Celeref 200 Tablets – Celecoxib Mouth Dissolving Tablets

    New Products,Uncategorized,Upcoming Products
  • Zolmiref

    Zolmiref Spray

    New Products,Uncategorized,Upcoming Products
  • Ipralist-L

    Levosalbutamol and Ipratropium Bromide Inhaler

    New Products,Uncategorized,Upcoming Products

Pharma Franchise & Third Party Enquiry

Please enable JavaScript in your browser to complete this form.
Loading

Speciality Range

  • Ortho & Surgery Range
  • Cardiac Range
  • Gastro Range
  • ENT Range
  • Gynae Range
  • Diabetic Range
  • Neuro & Psychia
  • Derma Range
  • General Physician Range
  • Ayurvedic
  • Dental Range
  • Critical Care Range
  • Ophthalmic Range
  • Pediatric Range
  • Urology Range

Short Links

  • Home
  • PCD Franchise
  • Third Party Pharma Manufacturing
  • Recently Launched
  • Latest Blog
  • Contact Us

Pharma Franchise & Third Party Enquiry

Please enable JavaScript in your browser to complete this form.
Loading

Recent Posts

  • India Approves Its First Dengue Vaccine August 19, 2026
  • Windlas PCD Pharma Franchise Company | Biophar Lifesciences July 31, 2026
  • Semaglutide Injection 8mg – Pcd Pharma Franchise July 29, 2026
  • Semaglutide Injection for Type 2 Diabetes and Weight Management July 27, 2026
  • LAYZID AV – Ceftazidime 2000 mg + Avibactam 500 mg Injection July 21, 2026

Contact Us

Biophar Lifesciences Pvt. Ltd.

Gulshan Rawat (Director)
Address
A.O-Office No-20,Paras Down Square Mall, Zirakpur
R.O-HB NO.234,Pabhat,Zirakpur SAS Nagar(Mohali)

+91-9888871967

biopharls@gmail.com

Biophar Lifesciences Pvt Ltd | SEO & Online Promotions by Growchip | IT Support by : Growchip